ClinicalTrials.govpublic full text
A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients
multiple myeloma, response rate, peripheral stem cell transplant, safety, tolerability, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 869929
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.